Loading…
Rational design and analysis of an Escherichia coli strain for high-efficiency tryptophan production
l -tryptophan ( l -trp) is a precursor of various bioactive components and has great pharmaceutical interest. However, due to the requirement of several precursors and complex regulation of the pathways involved, the development of an efficient l -trp production strain is challenging. In this study,...
Saved in:
Published in: | Journal of industrial microbiology & biotechnology 2018-05, Vol.45 (5), p.357-367 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | l
-tryptophan (
l
-trp) is a precursor of various bioactive components and has great pharmaceutical interest. However, due to the requirement of several precursors and complex regulation of the pathways involved, the development of an efficient
l
-trp production strain is challenging. In this study,
Escherichia coli
(
E. coli
) strain KW001 was designed to overexpress the
l
-trp operator sequences (
trpEDCBA
) and 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase (
aroG
fbr
). To further improve the production of
l
-trp, pyruvate kinase (
pykF
) and the phosphotransferase system HPr (
ptsH
) were deleted after inactivation of repression (
trpR
) and attenuation (attenuator) to produce strain KW006. To overcome the relatively slow growth and to increase the transport rate of glucose, strain KW018 was generated by combinatorial regulation of glucokinase (
galP
) and galactose permease (
glk
) expression. To reduce the production of acetic acid, strain KW023 was created by repressive regulation of phosphate acetyltransferase (
pta
) expression. In conclusion, strain KW023 efficiently produced 39.7 g/L of
l
-trp with a conversion rate of 16.7% and a productivity of 1.6 g/L/h in a 5 L fed-batch fermentation system. |
---|---|
ISSN: | 1367-5435 1476-5535 |
DOI: | 10.1007/s10295-018-2020-x |